Trial intelligence / Profile preview

Midodrine and Albumin for Renal Function in Cirrhosis

NCT01133795Phase 2Completed

Sponsor
Hospital Clínic de Barcelona
Start
Feb 2010
Primary completion
Jun 2016
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of midodrine, albumin (human) in Cirrhosis, renal impairment (RI), sponsored by Hospital Clínic de Barcelona. Started Feb 2010; status: completed.

02

Drugs

midodrinealbumin (human)
03

Conditions

Cirrhosisrenal impairment (RI)

Beyond the preview

Go deeper on NCT01133795.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01133795.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call